What are the diagnostic criteria for Thrombotic Thrombocytopenic Purpura (TTP) in a pediatric patient with a recent history of diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Thrombotic Thrombocytopenic Purpura (TTP)

In a pediatric patient with recent diarrhea, TTP diagnosis requires ADAMTS13 activity <10 IU/dL, but the clinical context strongly suggests STEC-HUS rather than TTP, making immediate ADAMTS13 testing critical to distinguish between these two life-threatening conditions. 1

The Critical Discriminator: ADAMTS13 Activity

  • ADAMTS13 activity <10 IU/dL is diagnostic of TTP, while normal or mildly reduced levels indicate atypical HUS or STEC-HUS 1, 2
  • Measure ADAMTS13 activity immediately when thrombotic microangiopathy (TMA) is suspected, as this single test definitively distinguishes TTP from HUS 1
  • Do not delay treatment while awaiting ADAMTS13 results, as atypical HUS requires immediate complement inhibitor therapy while TTP requires plasma exchange 1

Essential Laboratory Workup

When any patient presents with anemia plus thrombocytopenia, immediately order the following tests 1:

  • Complete blood count with peripheral blood smear - >1% schistocytes favors TMA, though absence does not exclude diagnosis 1
  • Haptoglobin - reduced in both TTP and HUS 1
  • LDH and indirect bilirubin - elevated in both conditions 1
  • Direct Coombs test - negative in both, confirming non-immune hemolysis 1
  • ADAMTS13 activity - the key discriminator 1
  • Stool testing for verocytotoxin-producing E. coli (VTEC/STEC) - necessary to diagnose STEC-HUS 1
  • Creatinine and urinalysis - essential to assess renal involvement 1

Clinical Features Distinguishing TTP from HUS in Pediatric Patients with Diarrhea

Features Favoring STEC-HUS (More Likely in This Case):

  • Preceding diarrheal illness, especially bloody diarrhea 4-5 days before HUS symptoms - this is the hallmark of STEC-HUS 1
  • Prominent acute renal injury with hematuria, proteinuria, and elevated creatinine 1
  • Less severe thrombocytopenia and fewer schistocytes compared to TTP 1
  • Less prominent neurological involvement than TTP 1
  • STEC-HUS typically occurs 4-5 days after diarrhea onset 1

Features Favoring TTP (Less Likely with Diarrhea History):

  • More prominent neurological involvement - confusion, seizures, focal deficits 1
  • Fever is more common in TTP than HUS 1
  • More gradual onset 1
  • Less severe renal involvement 1
  • More severe thrombocytopenia and more abundant schistocytes 1

Critical Timing Consideration

  • If platelet count obtained within 7 days after gastrointestinal illness onset is not <150,000/mm³, consider alternative diagnoses 1
  • Atypical HUS may have a shorter diarrhea period or simultaneous onset of diarrhea and HUS symptoms 1

Common Pitfalls to Avoid

  • Do not assume TTP based on the classic pentad - only 40% of TTP patients present with all five features (microangiopathic hemolytic anemia, thrombocytopenia, neurological dysfunction, renal dysfunction, and fever) 3, 4
  • Do not miss schistocytes on initial smear - repeat peripheral blood smear if clinical suspicion remains high, as schistocytes may not be present initially 4
  • Do not delay plasma exchange in suspected TTP - mortality is extremely high without prompt treatment 2, 5
  • In pediatric patients with bloody diarrhea, STEC-HUS is 10-fold more common than TTP - E. coli O157:H7 should be specifically sought 5

Physical Examination Red Flags

  • Splenomegaly excludes primary TTP and suggests alternative diagnoses such as Gaucher's disease, thalassemia, myelodysplasia, or schistosomiasis 6
  • The spleen is typically not palpable in TTP, though it may be palpable in approximately 12% of pediatric cases, particularly infants 6

Treatment Implications Based on Diagnosis

  • TTP requires immediate plasma exchange with fresh frozen plasma replacement and immunosuppression with corticosteroids 1, 2
  • Atypical HUS requires immediate complement inhibitor therapy 1
  • STEC-HUS is typically managed supportively without plasma exchange 1

References

Guideline

Distinguishing TTP from HUS

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Atypical Presentation of Thrombotic Thrombocytopenic Purpura without Hematological Features.

International journal of hematology-oncology and stem cell research, 2020

Guideline

Idiopathic Thrombocytopenic Purpura (ITP) Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.